Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study von Hughes, Timothy P, Saglio, Giuseppe, Geissler, Jan, Kim, Dong-Wook, Lomaia, Elza, Mayer, Jiri, Turkina, Anna, Kapoor, Shruti, Cardoso, Ana Paula, Nieman, Becki, Quenet, Sara, Cortes, Jorge E

Volltext